Personalized Pacing: A New Paradigm for Patients With Diastolic Dysfunction or Heart Failure With Preserved Ejection Fraction

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 123 participants.

Also called NCT04721314

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 123 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04721314
Other papers using this trial's data
  • Effect of Personalized Accelerated Pacing on Quality of Life, Physical Activity, and Atrial Fibrillation in Patients With Preclinical and Overt Heart Failure With Preserved Ejection Fraction: The myPACE Randomized Clinical Trial JAMA cardiology, 2023-03-01 DOI, PubMed 36723919, PMC9996402 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04721314. Randomized; double masking; primary purpose treatment. Start 2019-07-17 (actual); primary completion 2021-10-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Personalized Pacing: A New Paradigm for Patients With Diastolic Dysfunction or Heart Failure With Preserved Ejection Fraction
Acronym
myPACE
Condition
Pacemaker
Condition
Diastolic Dysfunction
Condition
Diastolic Heart Failure
Intervention (Device)
Adjustment of lower rate limit
Intervention (Device)
Maintenance of lower rate limit
Lead sponsor
University of Vermont (class: other)

Record details

Record id
cardio:ct-nct04721314
Content hash
754a9092b18c3e5219e6d121c102d767886702c684117d82004a46b76623bcc3